Liver GI Centre

Indonesia has the third highest prevalence of Hepatocellular (HCC) liver cancer worldwide. 30 million Indonesians are living with Hepatitis B and Hepatitis C, and 15 million of this group will develop Chronic Liver Disease (CLD). 10% of Indonesians with CLD will develop liver cancer.

Opening in 2011, and located within the MRCCC building, The Liver GI Centre employs Indonesia’s top Internist Gastrohepatologists to work as a cohesive team, providing diagnosis and treatment of the country’s most common liver and GI diseases.

The Centre’s facilities are located on the 23rd and 25th floors, and diagnostic facilities include: Endoscopy, ERCP (combined endoscopy and fluoroscopy) and Imaging.